Skip to main content
Log in

Reviewing cost-effectiveness evidence for phosphate binders in hyperphosphataemia in CKD

  • Review
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Chaiyakittisopon K, et al. Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations. European Journal of Health Economics : 6 Mar 2021. Available from: URL: https://doi.org/10.1007/s10198-021-01275-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reviewing cost-effectiveness evidence for phosphate binders in hyperphosphataemia in CKD. PharmacoEcon Outcomes News 874, 26 (2021). https://doi.org/10.1007/s40274-021-7569-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7569-3

Navigation